Combining these existing research studies and our findings, CEMIP might promote the occurrence and development of tumors via participating in the formation of TME including both ECM and the immune microenvironment (immune cells), indicating that CEMIP may be a promisingly therapeutic target for advanced BC. Here, CEMIP is linked to breast cancer.